Lifestyle counseling, combined with diet and exercise, reduces hypertension and improves cardiovascular outcomes.
Women experienced the same CV benefits in statin trials, despite having slightly elevated on-treatment LDL cholesterol.
Elevated baseline blood pressure was linked to higher 6-month CVD incidence.
Patients with diabetes had more CV risk factors and higher rates of noninvasive testing positivity.
Time to presentation grew for every unit increase in patient's hemoglobin A1c level.
HRT in postmenopausal women was linked to lower CAC scores and a lower risk of long-term, all-cause mortality.
Your first look at what to watch for during ACC 2017.
Sign Up for Free e-Newsletters
Check out what's trending
Endocrinology Advisor Articles
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Canagliflozin Trial for T2D With CKD Stopped Early Due to Positive Results
- Type 2 Diabetes and Alzheimer Disease: What's the Connection?
- Risk for Hypoglycemia During Titration With Insulin Glargine 100 U/mL in T2D
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Effect of SGLT2 Inhibitors on Heart Failure-Related Hospitalization, Below-Knee Amputation
- Nutraceuticals Containing Equol May Be Effective for Postmenopausal Symptoms
- Conservative Monitoring Strategy for Non-Functioning Pituitary Adenomas Evaluated
- FDA: Some Rx Drugs May Become Available Without Seeing a Doctor
- PM2.5 Contributes to Burden of Diabetes Mellitus Globally